Yüklüyor......
Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
Psoriasis is a chronic T-cell-mediated inflammatory disease that primarily affects the skin and joints. Patients with moderate to severe psoriasis constitute about 30% of the psoriasis population. Treatment of this group is challenging due to the long-term side effects, toxicities and inconvenience...
Kaydedildi:
Asıl Yazarlar: | , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047941/ https://ncbi.nlm.nih.gov/pubmed/21437059 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|